secwatch.observer — SEC 8-K summary
======================================

Issuer:     MERIT MEDICAL SYSTEMS INC (MMSI)
CIK:        0000856982
Form:       8-K
Filed at:   2025-02-25T23:59:59+00:00
Accession:  0000856982-25-000012
Event type: earnings
Sentiment:  positive
Materiality: 0.75
Item codes: 2.02, 7.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Merit Medical Q4 revenue $355M (+9.4%); Non-GAAP EPS $0.93 (+25.8%); FY 2025 guidance issued
--------------------------------------------------------------------------------

- Q4 2024 revenue $355.2M, up 9.4% YoY; constant currency revenue up 10.1%; organic constant currency up 6.1%.
- Non-GAAP EPS $0.93, up 25.8%; GAAP EPS $0.46, down 2.6%. Non-GAAP operating margin improved to 19.6% from 16.6%.
- Full year 2024 revenue $1.357B (+7.9%); Non-GAAP EPS $3.46 (+21.3%); free cash flow $185.7M (+67.5%).
- Completed acquisition of Cook Medical lead management portfolio; FDA PMA received for Wrapsody dialysis device.
- FY 2025 guidance: revenue $1.47-1.49B (8-10% growth); Non-GAAP EPS $3.58-$3.70 (4-7% growth).

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/856982/000085698225000012/0000856982-25-000012-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/856982/000085698225000012/mmsi-20250225x8k.htm
  HTML page:      https://secwatch.observer/filing/0000856982-25-000012

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer